DCGI orders withdrawal of AstraZeneca’s cancer drug Olaparib for certain treatments

DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alerts

Drug controller’s nod for Omicron-specific mRNA-based vaccine

Zero tolerance on spurious medicines, 71 firms issued notices: Mandaviya on cough syrup row

Mandatory testing of cough syrup before exports, DCGI asks labs to give top priority to such samples

Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence

Deaths linked to cough syrups: Govt panel says info shared by WHO so far inadequate to determine aetiology

WHO alert on cough syrups ‘alarming’, there are missing links that need to be probed: Expert

Drug regulator’s nod sought for phase-3 study of intranasal Covid vaccine in 5-18 age group

Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

Covaxin gets DCGI nod for 6-12 age group, Corbevax approved for 5-12 bracket

Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease

DCGI grants restricted EUA to Covid jab Corbevax for 12-18 age group

DCGI grants restricted EUA for Covid jab Corbevax for 12-18 yrs age group

Serum Institute seeks DCGI’s approval for Covishield as booster dose

DCGI approves Bharat Biotech’s Covaxin for children in 2-18 age group

Zydus Cadila seeks emergency-use nod from DCGI for its Covid-19 vaccine

Cipla gets DCGI nod to import Moderna’s Covid-19 vaccine for restricted emergency use in India

Serum Institute of India applies to DCGI to manufacture Covid vaccine Sputnik V

Norms for clearing foreign-made Covid-19 vaccines eased by DCGI

Zydus Cadila seeks DCGI nod for human clinical trials of antibodies cocktail to treat COVID-19

DCGI approves Phase 2, 3 clinical trials of Bharat Biotech’s Covaxin for 2 -18 year-olds

Bharat Biotech seeks DCGI’s nod to extend shelf life of Covaxin

DCGI gives nod for restricted emergency use of Russian COVID-19 vaccine Sputnik V in India: Sources

DCGI extends shelf life of Covishield from 6 to 9 months

Congress leaders raise concern over DCGI approval to indigenous Covid-19 vaccine

Zydus Cadila receives DCGI nod for NAFLD drug in India

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

DCGI and institutional ethics committee investigating claim of adverse event in COVID vaccine trial: Officials

Dr Reddy’s, RDIF get DCGI nod for clinical trial of COVID-19 vaccine Sputnik V in India

What is the ‘Feluda’ Test for Covid-19 approved by India?

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine

DCGI orders Serum Institute of India to suspend recruitment for Oxford Covid-19 vaccine trials

Serum Institute pauses COVID-19 vaccine trials in India

Latest Additions

Will investigate all scams of previous BJP term: DCM D K Shivakumar

Nadda terms Congress ‘parasite party’, says it weakens alliance partners

Bill to prevent disqualification of political secretaries to CM tabled in Karnataka assembly

Dakshina Kannada: Holiday for Schools and PUCs on July 20

Heavy rain: Holiday declared for Schools and PUCs in Udupi for July 20

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.